ometendoОжирение и метаболизмObesity and metabolism2071-87132306-5524Endocrinology Research Centre10.14341/2071-8713-4853ometendo-4853Research ArticleСтатьиArticlesЭффективность использования метформина при нейроциркуляторной нестабильности у детей с ожирениемEffektivnost' ispol'zovaniya metformina pri neyrotsirkulyatornoy nestabil'nosti u detey s ozhireniemGnusaevS F-DianovO A-YakovlevB N-20051509200523№3 (2005)4345Copyright © Gnusaev S.F., Dianov O.A., Yakovlev B.N., 20052005Gnusaev S.F., Dianov O.A., Yakovlev B.N.Gnusaev S.F., Dianov O.A., Yakovlev B.N.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.omet-endojournals.ru/jour/article/view/4853ReferencesБелозеров Ю.М., Ибрагимов М.С. Нейроциркуляторная нестабильность у подростков.- Томск.- 2004; с.125.Белозеров Ю.М., Ибрагимов М.С. Нейроциркуляторная нестабильность у подростков.- Томск.- 2004; с.125.Бутрова С.А. Метаболический синдром: патогенез, клиника, диагностика, подходы к лечению. РМЖ.- 2001.- №2(9).- с.56-60.Бутрова С.А. Метаболический синдром: патогенез, клиника, диагностика, подходы к лечению. РМЖ.- 2001.- №2(9).- с.56-60.Леонтьева И.В. Артериальная гипертензия у детей и подростков. //Прилож. Рос. Вестник перинат. и педиатрии.- М.; 2000; с.25-28.Леонтьева И.В. Артериальная гипертензия у детей и подростков. //Прилож. Рос. Вестник перинат. и педиатрии.- М.; 2000; с.25-28.Макаров Л.М. Холтеровское мониторирование.- М.: Медпрактика.- 2000; с. 49-64.Макаров Л.М. Холтеровское мониторирование.- М.: Медпрактика.- 2000; с. 49-64.Aviles-Santa L., Binding J., Raskin P. Effects of metformin in patients with poorly controlled, insulin-treated type 2 diabetes mellitus. A randomized, double-blind, placebo-control treal. Ann. Intern. Med. 1999; 131:132-8.Aviles-Santa L., Binding J., Raskin P. Effects of metformin in patients with poorly controlled, insulin-treated type 2 diabetes mellitus. A randomized, double-blind, placebo-control treal. Ann. Intern. Med. 1999; 131:132-8.Crowford M.H., Bernstein N., Deedvania P.C., DiMarco J.P. et al. ACC/AHA guidelines for ambulatory electrocardiography: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 1999; 34:912-48.Crowford M.H., Bernstein N., Deedvania P.C., DiMarco J.P. et al. ACC/AHA guidelines for ambulatory electrocardiography: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 1999; 34:912-48.DeFronzo R.A. Pharmacologic therapy for type 2 diabetes mellitus. Ann. Intern. Med. 1999; 131:281-303.DeFronzo R.A. Pharmacologic therapy for type 2 diabetes mellitus. Ann. Intern. Med. 1999; 131:281-303.Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention of metformin. N. Eng. J. Med. 2002; 346:349-403.Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention of metformin. N. Eng. J. Med. 2002; 346:349-403.United Kingdom Prospective Diabetes Study (UKPDS) 24: a 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy. United Kingdom Prospective Diabetes Study Group. Ann. Intern. Med. 1998; 128:165-75.United Kingdom Prospective Diabetes Study (UKPDS) 24: a 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy. United Kingdom Prospective Diabetes Study Group. Ann. Intern. Med. 1998; 128:165-75.Wiernsperger N.F. Metformin: Intrinsic vasculoprotective properties. Diabetes Technology and Therapeutics 2000; 2(2):259-72.Wiernsperger N.F. Metformin: Intrinsic vasculoprotective properties. Diabetes Technology and Therapeutics 2000; 2(2):259-72.
The authors declare that there are no conflicts of interest present.